Ad
related to: atomoxetine in adults treatment
Search results
Results from the WOW.Com Content Network
Atomoxetine is sometimes used in the treatment of cognitive impairment and frontal lobe symptoms due to conditions like traumatic brain injury (TBI). [48] [49] It is used to treat ADHD-like symptoms such as sustained attentional problems, disinhibition, [50] lack of arousal, fatigue, and depression, including symptoms from cognitive disengagement syndrome. [48]
Attention deficit hyperactivity disorder management options are evidence-based practices with established treatment efficacy for ADHD.Approaches that have been evaluated in the management of ADHD symptoms include FDA-approved pharmacologic treatment and other pharmaceutical agents, psychological or behavioral approaches, combined pharmacological and behavioral approaches, cognitive training ...
The non-stimulant atomoxetine (Strattera) may be an effective treatment for adult ADHD. Although atomoxetine has a half-life similar to stimulants, it exhibits a delayed onset of therapeutic effects similar to antidepressants. Unlike stimulants, which are generally controlled substances, atomoxetine lacks addictive potential.
One in four U.S. adults suspects they may have ADHD and drugs are a first line of treatment for this condition. But what does research say about their impact on the brain and quality of life?
The slow and long-acting nonstimulant atomoxetine (Strattera), is primarily a norepinephrine reuptake inhibitor and, to a lesser extent, a dopamine reuptake inhibitor. [14] It is sometimes prescribed in adults who do not get enough vigilant concentration response from mixed amphetamine salts (Adderall) or get too many side effects.
Atomoxetine may be used to treat CDS, [19] as multiple randomised controlled clinical trials have found that it is an effective treatment. [19] [20] [22] In contrast, multiple other RCTs have shown that it responds poorly to methylphenidate. [52] [53] [54] [55]
Atomoxetine has been shown to significantly improve academic performance. [295] [296] Meta-analyses and systematic reviews have found that atomoxetine has comparable efficacy, equal tolerability and response rate (75%) to methylphenidate in children and adolescents. In adults, efficacy and discontinuation rates are equivalent. [297] [298] [299 ...
[31] [32] Atomoxetine (Strattera) is another potent and selective NRI which is also effective and well tolerated treatment for adults with ADHD. This drug was the first ADHD treatment to be specially approved for adult use. Studies showed that atomoxetine is a nonstimulant and carries negligible risk of abuse.
Ad
related to: atomoxetine in adults treatment